Replies to post #11282 on United Health Products Inc (UEEC)

[trusttheman]

Key point though Wave in the press release is that the last two batches they tested weren't needed for FDA approval. If you remember, they produced batch one which matched up identically with clinical trials. That is what they needed for approval from my understanding. It seems they are doing more testing to not only make the company more attractive but give them insurance if the company needs to produce the product for a quarter. To take business away to increase offers. I stress, they have produced a batch that matched up identically with clinical trials. So a buying company would have to make sure mass production worked. It looks like they want mass production to work under their watch to give them more options.

[Waverunners]

So because the pps stayed within range of the past few months (which clearly it isn’t anymore) everything is cool?
Even though the range of the last few months was the lowest in 5 YEARS!
Not setting the bar to high there are you.
That’s like telling your Child who was a A+ student as a Freshman but fell to a D- as a Senior due to lazy mistakes…” that’s OK son, because you were a D student last semester as well. Who cares if you now have limited opportunities “

As Hemostyp creeps towards the finish line you want the pps to be going up not down (or equal to its worst Q in 5 years)
Whether this is a binary event or not, the higher the pps the better for maximizing value.

No matter how “positive “ you want to sound, every delay, mistake and missed opportunity causes further dilution, loans, payments via shares. That is not good for shareholder value.